P-280Pembrolizumab versus physician-choice chemotherapy for previously treated patients with advanced/metastatic squamous or adenocarcinoma of the esophagus or Siewert I adenocarcinoma of the esophagogastric junction (EGJ): Randomized, phase 3 KEYNOTE-18

ABSTRACT:

SUBMITTER: Toshihiko D 

PROVIDER: S-EPMC4984067 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature